We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis Stops Drug Marketing Amid Safety Concerns

Law360 (March 30, 2007, 12:00 AM EDT) -- Nudged by the U.S. Food and Drug Administration, Switzerland’s Novartis on Friday agreed to stop marketing the drug Zelnorm amid concerns the drug could trigger serious heart problems.

The FDA asked...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.